微流体元件市场－全球产业规模、份额、趋势、机会及预测（依产品、产业、区域及竞争格局划分，2021-2031年）

全球微流体元件市场预计将从 2025 年的 59.1 亿美元成长到 2031 年的 100.7 亿美元，复合年增长率达到 9.29%。

这些组件由微型帮浦、阀门、晶片和感测器等专用精密元件组成，旨在实现对亚毫米级微通道内流体的操控。市场成长的主要驱动力是照护现场(POC) 需求的不断增长以及高通量筛检在药物研发中日益广泛的应用。这些领域依赖微流体系统来最大限度地减少样本用量并加快分析速度，从而促进个人化医疗的发展。 SEMI 的报告反映了这一强劲的需求，报告指出，作为微流体造基础的 MEMS 和感测器的全球晶圆厂资本支出将在 2024 年达到约 120 亿美元的历史新高。

儘管市场成长迅速，但仍面临一项重大挑战：组件间接口缺乏标准化，导致模组化零件难以组装成整合系统。这种碎片化会阻碍大规模扩充性，并增加寻求建造互通解决方案的製造商的开发成本。此外，医疗设备认证的严格法规结构延长了产品开发週期，有可能延缓先进微流体技术的商业化应用。

市场驱动因素

随着医疗系统日益重视快速、分散的检测方案，照护现场（POC）设备需求的不断增长成为全球微流体组件市场的关键驱动力。微流体技术对于最大限度地减少试剂用量、将复杂的检测功能整合到携带式晶片上至关重要，从而能够在传统医院环境之外实现即时临床决策。这种向模组化诊断平台的转变，持续推动着对能够高精度处理亚微升液体的精密微型帮浦和感测器的需求。生物梅里埃公司于2025年11月发布的《2025年第三季业务回顾》充分展现了这项驱动因素的商业性实力。报告显示，该公司基于微流体技术的SPOTFIRE系统实现了114%的年成长，全球装置容量超过5,500台。

同时，微流体技术在药物发现和高通量筛检的应用日益广泛，尤其是在基因组学和空间生物学领域，这为市场带来了新的机会。製药研究人员正利用微流体晶片实现样品製备的自动化，并进行高解析度的单细胞分析，从而在降低营运成本的同时加速标靶识别。这一应用在领先创新企业的财务表现中得到了充分体现。例如，10x Genomics在2025年11月发布的「2025年第三季」财务报告中指出，受组织分析工具强劲需求的推动，其空间分析耗材收入增长了19%，达到3540万美元。此外，Standard BioTools在2025年1月宣布，预计年销售额将达到约1.74亿美元，进一步印证了生物医学研究领域对先进微流体技术的持续依赖。

市场挑战

微流体元件市场扩充性和商业性化成熟的一大障碍是缺乏标准化的元件介面。目前，该产业面临设计通讯协定碎片化的挑战，各製造商生产的微型泵浦、阀门和感测器均采用专有的连接方式，导致彼此产品互不相容。这种缺乏通用标准的现状迫使开发人员耗费大量时间和金钱进行客製化，才能将不同的元件整合到功能係统中。由此导致的「即插即用」互通性的缺失，阻碍了大规模生产的效率，推高了单位成本，并将该技术限制在小众应用领域，从而阻碍了其广泛的商业性化应用。

这种技术碎片化直接阻碍了市场成长，限制了半导体产业在整个生态系统中利用大规模生产能力的能力。儘管製造工厂配备了大规模生产所需的设备，但由于无法实现微流体设计的标准化，造成了瓶颈，限制了产能，并延缓了诊断解决方案的上市时间。根据SEMI预测，到2024年，全球半导体製造能力预计将成长6.4%，月产量将超过3,000万片晶圆。这凸显了由于这些整合挑战，微流体开发人员仍然难以获得庞大的工业规模。如果没有一个统一的介面框架来简化组装并降低开发复杂性，市场就无法充分利用现有的製造基础设施来满足不断增长的全球需求。

市场趋势

器官晶片（OoC）模型的商业化程度不断提高，为药物安全性测试提供了一种生理学上精确的动物实验替代方案，从而正在改变微流体市场。这一趋势的驱动力在于市场对高保真人体组织模型的需求，这些模型能够可靠地预测药物疗效，并减少代价高昂的临床试验失败。为了应对这一需求，开发人员正在设计整合式高通量系统，以简化用于常规工业应用的3D微组织的培养和分析。为了展示这种向可扩展平台的转变，CN Bio在2025年10月的新闻稿「CN Bio推出整合式器官晶片平台」中宣布推出其PhysioMimix Core系统。该系统支援同时对多达288个样本进行高通量筛检，从而加速药物研发进程。

同时，用于连续监测的可穿戴微流体生物感测器的兴起，正将这项技术拓展到个人化医疗保健和工业安全领域。与静态的照护现场诊断测试不同，这些非侵入式设备利用复杂的微通道即时采集和分析汗液和组织间液，从而动态地提供诸如水合水平和电解质平衡等生物标誌物的资讯。这项技术吸引了大量投资，用于扩大生产规模，并将基于云端的分析功能整合到从精英运动员表现到远端患者监护等各种应用中。 MobiHealthNews 在 2025 年 2 月发表的一篇题为《Epicore Biosystems资金筹措2600 万美元以扩展汗液感测可穿戴技术》的报导中指出，Epicore Biosystems 已获得 2600 万美元的 B 轮资金筹措，用于在全球范围内推广其基于微流体技术的补水和代谢资金解决方案，这表明其基于微流控技术的补水和代谢资金。

目录

第一章概述

第二章调查方法

第三章执行摘要

第四章：客户评价

第五章 全球微流体元件市场展望

• 市场规模及预测
  • 按金额
• 市占率及预测
  • 副产品（阀门（电磁阀、流量控制阀、止回阀、梭阀、洩压阀、比例阀、其他阀门）、流量/压力控制器、流量/压力感测器、微型帮浦、喷嘴、微针等）
  • 按产业划分（石油和天然气、医疗、航太和国防、消费性电子、汽车、其他产业）
  • 按地区
  • 按公司（2025 年）
• 市场地图

6. 北美微流体元件市场展望

• 市场规模及预测
• 市占率及预测
• 北美洲：国家分析
  • 我们
  • 加拿大
  • 墨西哥

7. 欧洲微流体元件市场展望

• 市场规模及预测
• 市占率及预测
• 欧洲：国家分析
  • 德国
  • 法国
  • 英国
  • 义大利
  • 西班牙

8. 亚太地区微流体元件市场展望

• 市场规模及预测
• 市占率及预测
• 亚太地区：国家分析
  • 中国
  • 印度
  • 日本
  • 韩国
  • 澳洲

9. 中东和非洲微流体元件市场展望

• 市场规模及预测
• 市占率及预测
• 中东和非洲：国家分析
  • 沙乌地阿拉伯
  • 阿拉伯聯合大公国
  • 南非

10. 南美洲微流体元件市场展望

• 市场规模及预测
• 市占率及预测
• 南美洲：国家分析
  • 巴西
  • 哥伦比亚
  • 阿根廷

第十一章 市场动态

• 司机
• 任务

第十二章 市场趋势与发展

• 併购
• 产品发布
• 最新进展

第十三章 全球微流体元件市场：SWOT分析

第十四章：波特五力分析

• 产业竞争
• 新进入者的可能性
• 供应商电力
• 顾客权力
• 替代品的威胁

第十五章 竞争格局

• Parker Hannifin Corporation
• IDEX Corporation
• Fluigent SA
• Staiger GmbH & Co. KG
• SMC Corporation
• Camozzi Automation Spa Societa Unipersonale
• Aignep spa
• FIM Valvole Srl
• Humphrey Products Corporation
• Dolomite Microfluidics
• Cellix Ltd.
• Christian BUrkert GmbH & Co. KG

第十六章 策略建议

第十七章：关于研究公司及免责声明

The Global Microfluidic Components Market is projected to expand from USD 5.91 Billion in 2025 to USD 10.07 Billion by 2031, achieving a CAGR of 9.29%. These components, comprising specialized precision devices such as micropumps, valves, chips, and sensors, are engineered to manipulate and control fluids within sub-millimeter microchannels. Market growth is primarily driven by the rising demand for point-of-care diagnostics and the increasing application of high-throughput screening in pharmaceutical research. These sectors depend on microfluidic systems to minimize sample volume requirements and expedite analysis, thereby facilitating the transition toward personalized medicine. Reflecting this robust demand, SEMI reported in 2024 that global fab equipment spending for MEMS and sensors-a fundamental category for microfluidic manufacturing-reached a record high of approximately $12 billion.

Despite this growth, the market encounters a major challenge due to the lack of standardization across component interfaces, which complicates the integration of modular parts into unified systems. This fragmentation can impede mass scalability and inflate development costs for manufacturers striving to build interoperable solutions. Furthermore, rigorous regulatory frameworks regarding medical device approval can extend product development cycles, potentially delaying the commercial introduction of advanced microfluidic technologies.

Market Driver

The growing demand for point-of-care (POC) diagnostic devices acts as a primary catalyst for the Global Microfluidic Components Market, as healthcare systems increasingly favor rapid, decentralized testing options. Microfluidic technologies are critical for minimizing reagent usage and incorporating complex laboratory functions onto portable chips, enabling immediate clinical decision-making outside conventional hospital environments. This shift toward modular diagnostic platforms generates a consistent need for precision micropumps and sensors capable of handling sub-microliter volumes with high accuracy. The commercial strength of this driver is highlighted by bioMerieux's 'Third-Quarter 2025 Business Review' from November 2025, which noted that the company's microfluidic-based SPOTFIRE system achieved a 114% organic sales increase year-on-year, expanding its global installed base to over 5,500 instruments.

Concurrently, the increasing application of microfluidics in drug discovery and high-throughput screening is broadening market opportunities, especially within genomics and spatial biology. Pharmaceutical researchers utilize microfluidic chips to automate sample preparation and perform single-cell analysis with high resolution, speeding up target identification while lowering operational costs. This adoption is evident in the financial results of leading innovators; for instance, 10x Genomics reported in their 'Third Quarter 2025 Financial Results' in November 2025 that revenue for spatial consumables rose by 19% to $35.4 million, driven by strong demand for tissue analysis tools. Additionally, Standard BioTools reported preliminary full-year revenue of roughly $174 million in January 2025, underscoring the persistent industrial reliance on advanced microfluidic technologies for biomedical research.

Market Challenge

The absence of standardization across component interfaces poses a significant barrier to the scalability and commercial maturation of the microfluidic components market. Currently, the industry struggles with fragmented design protocols, where manufacturers produce micropumps, valves, and sensors with proprietary connections that are incompatible with those of other vendors. This lack of universal standards compels developers to undertake expensive and time-consuming customization efforts to combine disparate parts into functional systems. Consequently, the lack of "plug-and-play" interoperability prevents the efficiencies typically associated with mass production, keeping unit costs high and limiting the technology to niche applications rather than widespread commercial adoption.

This technical fragmentation directly hampers market growth by restricting the industry's ability to leverage the high-volume manufacturing capabilities of the broader semiconductor ecosystem. Although fabrication facilities are equipped for massive output, the inability to standardize microfluidic designs creates a bottleneck that limits throughput and delays time-to-market for diagnostic solutions. According to SEMI, in 2024, global semiconductor manufacturing capacity grew by 6.4 percent to exceed 30 million wafers per month, highlighting the immense industrial scale that remains largely inaccessible to microfluidic developers due to these integration challenges. Without a unified interface framework to streamline assembly and reduce development complexity, the market cannot fully capitalize on existing manufacturing infrastructure to meet rising global demand.

Market Trends

The increasing commercialization of organ-on-chip (OoC) models is reshaping the microfluidic components market by offering physiologically accurate alternatives to animal testing for pharmaceutical safety. This trend is fueled by the demand for high-fidelity human tissue models that can reliably predict drug efficacy, thereby reducing expensive clinical failures. Developers are responding by engineering integrated, high-throughput systems that streamline the culture and analysis of 3D microtissues for routine industrial use. Demonstrating this shift toward scalable platforms, CN Bio announced in their October 2025 press release, 'CN Bio Launches Unified Organ-on-a-Chip Platform,' the introduction of its PhysioMimix Core system, which supports high-throughput screening of up to 288 samples simultaneously to accelerate drug discovery pipelines.

Simultaneously, the rise of wearable microfluidic biosensors for continuous monitoring is expanding the technology into personalized health and industrial safety sectors. Unlike static point-of-care diagnostic tests, these non-invasive devices employ complex micro-channels to capture and analyze sweat or interstitial fluid in real-time, providing dynamic insights into biomarkers such as hydration levels and electrolyte balance. This capability is attracting significant investment to scale manufacturing and integrate cloud-based analytics for applications ranging from elite sports performance to remote patient monitoring. Highlighting the robust financial confidence in this sector, MobiHealthNews reported in February 2025, in the article 'Epicore Biosystems scores $26M to expand sweat-sensing wearable technology,' that Epicore Biosystems secured $26 million in Series B funding to scale its microfluidic hydration and metabolic health solutions globally.

Key Market Players

• Parker Hannifin Corporation
• IDEX Corporation
• Fluigent SA
• Staiger GmbH & Co. KG
• SMC Corporation
• Camozzi Automation Spa Societa Unipersonale
• Aignep s.p.a.
• FIM Valvole Srl
• Humphrey Products Corporation
• Dolomite Microfluidics
• Cellix Ltd.
• Christian BUrkert GmbH & Co. KG

Report Scope

In this report, the Global Microfluidic Components Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Microfluidic Components Market, By Product

• Valves (Solenoid Valves, Flow Control Valves, Check Valves, Shuttle Valves, Pressure Relief Valves, Proportional Valves, Other Valves)
• Flow and Pressure Controllers
• Flow and Pressure Sensors
• Micropumps
• Nozzles
• Microneedles
• Others

Microfluidic Components Market, By Industry

• Oil & Gas
• Healthcare
• Aerospace & Defense
• Consumer Electronics
• Automotive
• Other Industries

Microfluidic Components Market, By Region

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Microfluidic Components Market.

Available Customizations:

Global Microfluidic Components Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Microfluidic Components Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Product (Valves (Solenoid Valves, Flow Control Valves, Check Valves, Shuttle Valves, Pressure Relief Valves, Proportional Valves, Other Valves), Flow and Pressure Controllers, Flow and Pressure Sensors, Micropumps, Nozzles, Microneedles, Others)
  • 5.2.2. By Industry (Oil & Gas, Healthcare, Aerospace & Defense, Consumer Electronics, Automotive, Other Industries)
  • 5.2.3. By Region
  • 5.2.4. By Company (2025)
• 5.3. Market Map

6. North America Microfluidic Components Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Product
  • 6.2.2. By Industry
  • 6.2.3. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Microfluidic Components Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Product
      • 6.3.1.2.2. By Industry
  • 6.3.2. Canada Microfluidic Components Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Product
      • 6.3.2.2.2. By Industry
  • 6.3.3. Mexico Microfluidic Components Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Product
      • 6.3.3.2.2. By Industry

7. Europe Microfluidic Components Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Product
  • 7.2.2. By Industry
  • 7.2.3. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. Germany Microfluidic Components Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Product
      • 7.3.1.2.2. By Industry
  • 7.3.2. France Microfluidic Components Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Product
      • 7.3.2.2.2. By Industry
  • 7.3.3. United Kingdom Microfluidic Components Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Product
      • 7.3.3.2.2. By Industry
  • 7.3.4. Italy Microfluidic Components Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Product
      • 7.3.4.2.2. By Industry
  • 7.3.5. Spain Microfluidic Components Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Product
      • 7.3.5.2.2. By Industry

8. Asia Pacific Microfluidic Components Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Product
  • 8.2.2. By Industry
  • 8.2.3. By Country
• 8.3. Asia Pacific: Country Analysis
  • 8.3.1. China Microfluidic Components Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Product
      • 8.3.1.2.2. By Industry
  • 8.3.2. India Microfluidic Components Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Product
      • 8.3.2.2.2. By Industry
  • 8.3.3. Japan Microfluidic Components Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Product
      • 8.3.3.2.2. By Industry
  • 8.3.4. South Korea Microfluidic Components Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Product
      • 8.3.4.2.2. By Industry
  • 8.3.5. Australia Microfluidic Components Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Product
      • 8.3.5.2.2. By Industry

9. Middle East & Africa Microfluidic Components Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Product
  • 9.2.2. By Industry
  • 9.2.3. By Country
• 9.3. Middle East & Africa: Country Analysis
  • 9.3.1. Saudi Arabia Microfluidic Components Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Product
      • 9.3.1.2.2. By Industry
  • 9.3.2. UAE Microfluidic Components Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Product
      • 9.3.2.2.2. By Industry
  • 9.3.3. South Africa Microfluidic Components Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Product
      • 9.3.3.2.2. By Industry

10. South America Microfluidic Components Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Product
  • 10.2.2. By Industry
  • 10.2.3. By Country
• 10.3. South America: Country Analysis
  • 10.3.1. Brazil Microfluidic Components Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Product
      • 10.3.1.2.2. By Industry
  • 10.3.2. Colombia Microfluidic Components Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Product
      • 10.3.2.2.2. By Industry
  • 10.3.3. Argentina Microfluidic Components Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Product
      • 10.3.3.2.2. By Industry

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Merger & Acquisition (If Any)
• 12.2. Product Launches (If Any)
• 12.3. Recent Developments

13. Global Microfluidic Components Market: SWOT Analysis

14. Porter's Five Forces Analysis

• 14.1. Competition in the Industry
• 14.2. Potential of New Entrants
• 14.3. Power of Suppliers
• 14.4. Power of Customers
• 14.5. Threat of Substitute Products

15. Competitive Landscape

• 15.1. Parker Hannifin Corporation
  • 15.1.1. Business Overview
  • 15.1.2. Products & Services
  • 15.1.3. Recent Developments
  • 15.1.4. Key Personnel
  • 15.1.5. SWOT Analysis
• 15.2. IDEX Corporation
• 15.3. Fluigent SA
• 15.4. Staiger GmbH & Co. KG
• 15.5. SMC Corporation
• 15.6. Camozzi Automation Spa Societa Unipersonale
• 15.7. Aignep s.p.a.
• 15.8. FIM Valvole Srl
• 15.9. Humphrey Products Corporation
• 15.10. Dolomite Microfluidics
• 15.11. Cellix Ltd.
• 15.12. Christian BUrkert GmbH & Co. KG

16. Strategic Recommendations

17. About Us & Disclaimer